Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y fibrilación auricular: datos del registro SEMI-COVID-19

Azaña Gómez, Javier; Pérez-Belmonte, Luis M; Rubio-Rivas, Manuel; Bascuñana, José; Quirós-López, Raúl; Taboada Martínez, María Luisa; Montero Hernandez, Esther; Roque-Rojas, Fernando; Méndez-Bailón, Manuel; Gómez-Huelgas, Ricardo.
Med. clín (Ed. impr.) ; 159(10): 457-464, noviembre 2022. tab
Artículo en Español | IBECS (España) | ID: ibc-212248

Documentos relacionados

  1. Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation.
  2. Environmental Exposome and Atrial Fibrillation: Emerging Evidence and Future Directions.
  3. Polypharmacy and Major Adverse Events in Atrial Fibrillation.
  4. Development and validation a nomogram for predicting new-onset postoperative atrial fibrillation following pulmonary resection.
  5. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
  6. Predictors of ibrutinib-associated atrial fibrillation: 5-year follow-up of a prospective study.
  7. [The impact of psychological resilience, as a component of intrinsic capacity, on the risk of developing atrial fibrillation.]
  8. Repeat ablation strategy for recurrent persistent atrial fibrillation: A propensity-matched score comparison between "2C3L" and "extensive ablation" approach.
  9. Resource use and cost associated with computerized decision support system and usual care in managing patients with atrial fibrillation: analysis of IMPACT-AF randomized trial data.
  10. Atrial Fibrillation.